CAMK4 and systemic lupus erythematosus: Targeted delivery of a CaMK4 inhibitor to podocytes preserved their ultrastructure, averted immune complex deposition and crescent formation, and suppressed proteinuria in lupus-prone mice, despite systemic autoimmunity remaining intact.